Status:
COMPLETED
Examination of Muscle Stiffness, Tenderness and Pressure Pain Thresholds During a Cycle of Botulinum Toxin A Treatment in Chronic Migraine Patients
Lead Sponsor:
Danish Headache Center
Conditions:
Chronic Migraine
Eligibility:
All Genders
18+ years
Brief Summary
Preventive treatment with botulinum toxin A injections is standard care for chronic migraine and follows the PREEMPT protocol. Patients are injected at 31 locations in the frontal, corrugator and proc...
Detailed Description
Study population The population considered for inclusion in the study is patients with CM treated with botulinum toxin A injections every third months at DHC. This is an observational study, and incl...
Eligibility Criteria
Inclusion
- Patients being treated (or are starting treatment) with botulinum toxin A injections in the clinical setting at the DHC. Treatment is based on confirmed CM-diagnosis according to the ICHD-III (4), diagnosed by headache specialists at DHC
- Aged 18 - 65 years
- Able to sign an informed consent
Exclusion
- Medication overuse headache
- Known cervical disorders, e.g. cervical spine disc prolapses, whiplash or spinal stenosis
- Change in other pharmacological preventive medication during the study period. Stable pharmacological preventive medication is allowed.
Key Trial Info
Start Date :
May 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2022
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT05328687
Start Date
May 1 2021
End Date
December 1 2022
Last Update
January 29 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Danish Headache Center
Glostrup Municipality, Denmark, 2600